Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Clinical trial NCT02495896 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02495896
Sponsor: University of Southern California
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma Metastatic Pancreatic Adenocarcinoma Non-Resectable Cholangiocarcinoma Pancreatic Adenocarcinoma Recurrent Gallbladder Carcinoma Recurrent Non-Small Cell Lung Carcinoma Stage III Pancreatic Cancer Stage IIIA Gallbladder Cancer Stage IIIA Non-Small Cell Lung Cancer Stage IIIB Gallbladder Cancer Stage IIIB Non-Small Cell Lung Cancer Stage IV Gallbladder Cancer

Start date: 2015-09-03
Primary completion: 2021-04-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.